Hood River Capital Management LLC Alkermes Plc. Transaction History

Hood River Capital Management LLC

  • $5.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $1.16 Million - $1.33 Million
45,688 Added 6.66%
731,630 $20.6 Million
Q4 2022

Feb 14, 2023
BUY
$21.94 - $26.24 $5.4 Million - $6.45 Million
245,952 Added 55.9%
685,942 $17.9 Million
Q3 2022

Nov 14, 2022
BUY
$22.0 - $31.87 $273,988 - $396,908
12,454 Added 2.91%
439,990 $9.83 Million
Q2 2022

Aug 15, 2022
BUY
$26.4 - $30.54 $11.3 Million - $13.1 Million
427,536 New
427,536 $12.7 Million

Others Institutions Holding ALKS

# of Institutions
362
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.9B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email